86936140 - BASILEA

Information

• Trademark
• 86936140

• Source

• Serial Number

  86936140

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  March 10, 2016
  8 years ago

• Transaction Date

  November 04, 2019
  5 years ago

• Status Date

  November 04, 2019
  5 years ago

• Published for Opposition Date

  August 09, 2016
  8 years ago

• Location Date

  May 16, 2019
  5 years ago

• Status Code

  606

• Current Location

  DIVISIONAL UNIT

  Employee Name

  JENKINS JR, CHARLES L

• Attorney Docket Number

  3005-0109

  Attorney Name

  Evan A. Raynes

  Law Office Assigned Location Code

  M30

• Owners

  • Basilea Pharmaceutica AG

Case File Statements

• CC0000: The color(s) blue and white is/are claimed as a feature of the mark.
• DM0000: The mark consists of the word "BASILEA" in blue surrounded by an oval in blue, with the interior of the oval in white.
• GS0011: Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions, the treatment of infections and diseases and in the research and development of pharmaceuticals in the treatment of dermatological conditions, the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use
• GS0051: Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Veterinary products and preparations, namely, for the treatment and prevention of infections caused by bacteria, and Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of infections caused by fungi, viruses, and rheumatoid arthritis; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of oncology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of allergy; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of anesthesiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; diagnostic preparations for medical clinical purposes; clinical medical reagents; all of the aforesaid for prescription only
• GS0421: Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations

Case File Event Statements

• 11/4/2019 - 5 years ago

  36 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6

• 11/4/2019 - 5 years ago

  35 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 5/18/2019 - 5 years ago

  34 - CORRECTED NOA E-MAILED Type: NOAC

• 5/16/2019 - 5 years ago

  33 - DIVISIONAL PROCESSING COMPLETE Type: DPCC

• 5/6/2019 - 5 years ago

  32 - DIVISIONAL REQUEST RECEIVED Type: DRRR

• 5/6/2019 - 5 years ago

  31 - TEAS REQUEST TO DIVIDE RECEIVED Type: ERTD

• 3/6/2019 - 5 years ago

  30 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 3/5/2019 - 5 years ago

  29 - EXTENSION 5 GRANTED Type: EX5G

• 2/27/2019 - 5 years ago

  28 - EXTENSION 5 FILED Type: EXT5

• 3/5/2019 - 5 years ago

  27 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 2/27/2019 - 5 years ago

  26 - TEAS EXTENSION RECEIVED Type: EEXT

• 9/21/2018 - 6 years ago

  25 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 9/19/2018 - 6 years ago

  24 - EXTENSION 4 GRANTED Type: EX4G

• 9/19/2018 - 6 years ago

  23 - EXTENSION 4 FILED Type: EXT4

• 9/19/2018 - 6 years ago

  22 - TEAS EXTENSION RECEIVED Type: EEXT

• 3/21/2018 - 6 years ago

  21 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 3/19/2018 - 6 years ago

  20 - EXTENSION 3 GRANTED Type: EX3G

• 3/19/2018 - 6 years ago

  19 - EXTENSION 3 FILED Type: EXT3

• 3/19/2018 - 6 years ago

  18 - TEAS EXTENSION RECEIVED Type: EEXT

• 9/26/2017 - 7 years ago

  17 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 9/23/2017 - 7 years ago

  16 - EXTENSION 2 GRANTED Type: EX2G

• 9/23/2017 - 7 years ago

  15 - EXTENSION 2 FILED Type: EXT2

• 9/23/2017 - 7 years ago

  14 - TEAS EXTENSION RECEIVED Type: EEXT

• 3/29/2017 - 7 years ago

  13 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 3/27/2017 - 7 years ago

  12 - EXTENSION 1 GRANTED Type: EX1G

• 3/27/2017 - 7 years ago

  11 - EXTENSION 1 FILED Type: EXT1

• 3/27/2017 - 7 years ago

  10 - TEAS EXTENSION RECEIVED Type: EEXT

• 10/4/2016 - 8 years ago

  9 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 8/9/2016 - 8 years ago

  8 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 8/9/2016 - 8 years ago

  7 - PUBLISHED FOR OPPOSITION Type: PUBO

• 7/20/2016 - 8 years ago

  6 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 6/28/2016 - 8 years ago

  5 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 6/22/2016 - 8 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 3/16/2016 - 8 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 3/15/2016 - 8 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 3/14/2016 - 8 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP